# SELUTION4SFA Trial

Study · id `cardio:ct-nct05132361` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05132361](<https://clinicaltrials.gov/study/NCT05132361>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05132361

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 300 participants.

## Technical summary

Registry record NCT05132361. Randomized; single masking; primary purpose treatment. Start 2022-12-01 (actual); primary completion 2026-07-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (enrolled count; ClinicalTrials.gov record NCT05132361, source copy `cardio:ctgov-nct05132361-2026-11-04`, retrieved 2026-11-18)
- Started: 2022-12-01 (actual) (ClinicalTrials.gov record NCT05132361, source copy `cardio:ctgov-nct05132361-2026-11-04`, retrieved 2026-11-18)
- Primary completion: 2026-07-25 (actual) (ClinicalTrials.gov record NCT05132361, source copy `cardio:ctgov-nct05132361-2026-11-04`, retrieved 2026-11-18)
- Completion: 2030-12-01 (anticipated) (ClinicalTrials.gov record NCT05132361, source copy `cardio:ctgov-nct05132361-2026-11-04`, retrieved 2026-11-18)
- Countries: United States; Austria; Germany; Hong Kong SAR China (ClinicalTrials.gov record NCT05132361, source copy `cardio:ctgov-nct05132361-2026-11-04`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05132361-2026-11-04`, retrieved 2026-11-18)

## The registry's words

- Brief title: SELUTION4SFA Trial
- Condition: Peripheral Arterial Disease
- Condition: Superficial Femoral Artery Stenosis
- Intervention (Device): SELUTION SLR™ 018 DEB
- Intervention (Device): Plain (Uncoated) Balloon Angioplasty (PTA)
- Lead sponsor: M.A. Med Alliance S.A.
- Lead sponsor class: INDUSTRY
- Collaborator: NAMSA
- Collaborator class: OTHER
- Collaborator: Cordis US Corp.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: M.A. Med Alliance S.A. (`cardio:org-m-a-med-alliance-s-a`)
- Registry lists this organization as a collaborator: Cordis US Corp. (`cardio:org-cordis-us-corp`)

## Provenance

Content hash: a2125487d77a4224cb9a2d564c142a827c9dbfb0a3df0e0a636397d1a71be40b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
